| Type: |
Conjugated Primary Antibody |
| Conjugated with: |
594, ALEXA FLUOR® |
| Host organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Protein/Peptide: |
ELMO2 |
| Specificity: |
This antibody reacts specifically with ELMO2 |
| Modification: |
No modification has been applied to this antibody |
| Modification site: |
None |
| Clonality: |
Polyclonal Antibody |
| Clone: |
Polyclonal Antibodies |
| Concentration: |
1ug per 1ul |
| Antigen Source: |
KLH conjugated synthetic peptide derived from human ELMO2 |
| Gene ID: |
63916 |
| Applications: |
IF(IHC-P) |
| Applications with corresponding dilutions: |
IF(IHC-P)(1:50-200) |
| Cross reactive species: |
Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens) |
| Cross Reactive Species details: |
However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species |
| Background information: |
DOCK1, Elmo1 associates with DOCK 180 and may influence phagocytosis and effect cell shape changes, Elmo2 interacts directly with Rho G in a GTP-dependent manner and forms a ternary complex with DOCK 180 to induce activation of Rac 1, Elmo3 acts in assocation with DOCK180 and Crk II and may be required in complex with DOCK180 to activate Rac/Rho small GTPases, RAC1 and ELMO mediate cytoskeletal rearrangements during phagocytosis of apoptotic cells and cell motility, Src family kinase mediated tyrosine phosphorylation of ELMO1 influences signaling through Elmo1/Crk/DOCK 180 pathways, The C, The RhoG-Elmo2-DOCK 180 pathway is required for activation of Rac 1 and cell spreading mediated by integrin, and ced-12 and their mammalian homologs CRKII, as well as for neurite outgrowth induced by nerve growth factor, ced-10, ced-5, elegans CED-12, elegans genes ced-2, Elmo (engulfment and cell motility) proteins share similarity to C |
| Purification method: |
Purified by Protein A |
| Storage: |
50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA |
| Excitation emission: |
590nm/617nm |
| Synonyms: |
CED12 ELMO-2 CED-12 KIAA1834 FLJ11656 |
| Also known as: |
ELMO2 Polyclonal Antibody |
| Other name: |
Anti-ELMO2 Polyclonal |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody |
| Properties: |
For facs or microscopy Alexa 1 conjugate |
| Conjugation: |
Alexa Fluor |
| Group: |
Polyclonals and antibodies |
| About: |
The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot |
| Gene target: |
ELMO2 |
| Short name: |
Anti-ELMO2 (Polyclonal) Fluor 594 |
| Technique: |
Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different  |
| Label: |
ALEXA |
| Alternative name: |
ALEXA Fluor 594, antibody to-engulfment and cellular motility 2 (polyclonal) |
| Alternative technique: |
polyclonals |
| Alternative to gene target: |
BT, ELMO2 and IDBG-79125 and ENSG00000062598 and 63916, Elmo2 and IDBG-212599 and ENSMUSG00000017670 and 140579, Plasma membranes, receptor tyrosine kinase binding, this GO :0005488 and binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005829 and cytosol and cellular component this GO :0005856 and cytoskeleton and cellular component this GO :0006909 and pha this GO cytosis and biological process this GO :0006915 and apoptotic process and biological process this GO :0016020 and membrane and cellular component this GO :0017124 and SH3 domain binding and molecular function this GO :0030971 and receptor tyrosine kinase binding and molecular function this GO :0038096 and Fc-gamma receptor signaling pathway involved in pha this GO cytosis and biological process this GO :0045087 and innate immune response and biological process this GO :0060326 and cell chemotaxis and biological process, this GO :0005488 : binding, this GO :0005488 : binding and also this GO :0005515 : protein binding and also this GO :0017124 : SH3 domain binding and also this GO :0030971 : receptor tyrosine kinase binding, this GO :0005515 : protein binding, this GO :0017124 : SH3 domain binding, this GO :0030971 : receptor tyrosine kinase binding, 48490 and IDBG-643064 and ENSBTAG00000003639 and 508361, engulfment and cell motility 2 |
| Identity: |
17233 |
| Gene: |
ELMO2 |
More about : ELMO2 |
| Long gene name: |
engulfment and cell motility 2 |
| Synonyms gene name: |
C, elegans) , engulfment and cell motility 2 (ced-12 homolog |
| Locus: |
20q13, 12 |
| Discovery year: |
2001-12-13 |
| GenBank acession: |
AF398886 |
| Entrez gene record: |
63916 |
| Pubmed identfication: |
11595183 |
| RefSeq identity: |
NM_022086 |
| Classification: |
Engulfment and cell motility proteins |
| Havana BLAST/BLAT: |
OTTHUMG00000033070 |